Cyril J Peter, PhD
About Me
Dr. Peter’s research focuses on identifying and characterizing novel proteins and molecular interactions involved in chromatin remodeling and epigenetic regulation in human vertebrae and brain. His goal is to translate those findings and develop new chromatin modifying drugs that have therapeutic potential for neuropsychiatric diseases. In addition, he will contribute to grants and projects for the Center of Excellence, organize a monthly seminar on psychiatric epigenetics, and serve as a mentor to graduate and postdoctoral students.
Prior to joining Mount Sinai, Dr. Peter was an instructor at Brudnick Neuropsychiatric Research Institute at the University of Massachusetts Medical School. During his training, he identified a novel chromatin protein complex, which may play a key role in epigenetic mechanisms in the brain.
Language
Position
About Me
Dr. Peter’s research focuses on identifying and characterizing novel proteins and molecular interactions involved in chromatin remodeling and epigenetic regulation in human vertebrae and brain. His goal is to translate those findings and develop new chromatin modifying drugs that have therapeutic potential for neuropsychiatric diseases. In addition, he will contribute to grants and projects for the Center of Excellence, organize a monthly seminar on psychiatric epigenetics, and serve as a mentor to graduate and postdoctoral students.
Prior to joining Mount Sinai, Dr. Peter was an instructor at Brudnick Neuropsychiatric Research Institute at the University of Massachusetts Medical School. During his training, he identified a novel chromatin protein complex, which may play a key role in epigenetic mechanisms in the brain.
Language
Position
Locations
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Peter has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Peter has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.